-
1
-
-
0029642252
-
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3.
-
Marchand M, Weynants P, Rankin E, et al. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 1995; 63:883-5.
-
Marchand M, Weynants P, Rankin E, et al. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 1995; 63:883-5.
-
(1995)
Int J Cancer
, vol.63
, pp. 883
-
-
Marchand, M.1
Weynants, P.2
Rankin, E.3
-
2
-
-
0029997742
-
Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens.
-
Jäger E, Bernhard H, Romero P, et al. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int J Cancer 1996; 66:162-9.
-
Jäger E, Bernhard H, Romero P, et al. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int J Cancer 1996; 66:162-9.
-
(1996)
Int J Cancer
, vol.66
, pp. 162
-
-
Jäger, E.1
Bernhard, H.2
Romero, P.3
-
3
-
-
0031941423
-
Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells.
-
Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med 1998; 4:328-32.
-
Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med 1998; 4:328-32.
-
(1998)
Nature Med
, vol.4
, pp. 328
-
-
Nestle, F.O.1
Alijagic, S.2
Gilliet, M.3
-
4
-
-
0031890206
-
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for treament of patients with metastatic melanoma.
-
Rosenberg SA, Yang JC, Schwartzentruber DJ, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for treament of patients with metastatic melanoma. Nature Med 1998; 4:321-7.
-
Rosenberg SA, Yang JC, Schwartzentruber DJ, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for treament of patients with metastatic melanoma. Nature Med 1998; 4:321-7.
-
(1998)
Nature Med
, vol.4
, pp. 321
-
-
Rosenberg, S.A.1
Yang, J.C.2
Schwartzentruber, D.J.3
-
5
-
-
0031880570
-
Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy.
-
Romero P, Cerottini J-C, Waanders GA. Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy. Mol Med Today 1998; 4:305-12.
-
Romero P, Cerottini J-C, Waanders GA. Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy. Mol Med Today 1998; 4:305-12.
-
(1998)
Mol Med Today
, vol.4
, pp. 305
-
-
Romero, P.1
Cerottini, J.-C.2
Waanders, G.A.3
-
6
-
-
0031436611
-
Monitoring of cancer patients undergoing active or passive immunotherapy.
-
Salgaller ML. Monitoring of cancer patients undergoing active or passive immunotherapy. J Immunother 1997; 20:1-14.
-
Salgaller ML. Monitoring of cancer patients undergoing active or passive immunotherapy. J Immunother 1997; 20:1-14.
-
(1997)
J Immunother
, vol.20
, pp. 1
-
-
Salgaller, M.L.1
-
7
-
-
0025255387
-
Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.
-
Ullman KS, Northrop JP, Verweij CL, Crabtree GR. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu Rev Immunol 1990; 8:421-52.
-
(1990)
Annu Rev Immunol
, vol.8
, pp. 421
-
-
Ullman, K.S.1
Northrop, J.P.2
Verweij, C.L.3
Crabtree, G.R.4
-
8
-
-
0029874657
-
T cell antigen receptor signal transduction pathways.
-
Cantrell D. T cell antigen receptor signal transduction pathways. Annu Rev Immunol 1996; 14:259-74.
-
(1996)
Annu Rev Immunol
, vol.14
, pp. 259
-
-
Cantrell, D.1
-
9
-
-
0028932731
-
The CTL's kiss of death.
-
Berke G. The CTL's kiss of death. Cell 1995; 81:9-12.
-
(1995)
Cell
, vol.81
, pp. 9
-
-
Berke, G.1
-
10
-
-
0031172162
-
Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition.
-
Valitutti S, Lanzavecchia A. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol Today 1997; 6:299-304.
-
(1997)
Immunol Today
, vol.6
, pp. 299
-
-
Valitutti, S.1
Lanzavecchia, A.2
-
11
-
-
0025286210
-
Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation.
-
Harding CV, Unanue ER. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 1990; 346:574-6.
-
(1990)
Nature
, vol.346
, pp. 574
-
-
Harding, C.V.1
Unanue, E.R.2
-
12
-
-
0014251127
-
Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogenic target cells in vitro; inhibition by isoantibodies and by drugs.
-
Brunner KT, Mauel J, Cerottini JC, Chapus B. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogenic target cells in vitro; inhibition by isoantibodies and by drugs. Immunolology 1968; 14:181-96.
-
(1968)
Immunolology
, vol.14
, pp. 181
-
-
Brunner, K.T.1
Mauel, J.2
Cerottini, J.C.3
Chapus, B.4
-
13
-
-
0032055984
-
Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo.
-
Spaeny-Dekking EH, Hanna WL, Wolbink AM, et al. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J Immunol 1998; 160:3610-16.
-
(1998)
J Immunol
, vol.160
, pp. 3610
-
-
Spaeny-Dekking, E.H.1
Hanna, W.L.2
Wolbink, A.M.3
-
14
-
-
0020506697
-
The relationship between immune interferon production and proliferation in antigen-specific MHC-restricted T cell lines and clones.
-
Hecht TT, Longo DL, Matis LA. The relationship between immune interferon production and proliferation in antigen-specific MHC-restricted T cell lines and clones. J Immunol 1983; 131:1049-55.
-
(1983)
J Immunol
, vol.131
, pp. 1049
-
-
Hecht, T.T.1
Longo, D.L.2
Matis, L.A.3
-
15
-
-
0030590638
-
A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides.
-
Mayer S, Scheibenbogen C, Lee KH, et al. A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides. J Immunol Methods 1996; 197:131-7.
-
(1996)
J Immunol Methods
, vol.197
, pp. 131
-
-
Mayer, S.1
Scheibenbogen, C.2
Lee, K.H.3
-
16
-
-
0027459260
-
Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens.
-
Hom SS, Schwarzentruber DJ, Rosenberg SA, Topalian SL. Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens. J Immunother 1993; 13:18-30.
-
(1993)
J Immunother
, vol.13
, pp. 18
-
-
Hom, S.S.1
Schwarzentruber, D.J.2
Rosenberg, S.A.3
Topalian, S.L.4
-
17
-
-
0028136948
-
Patterns of cytokine release of unselected and CD8-selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivo.
-
Steger GG, Pierce WC, Figlin R, et al. Patterns of cytokine release of unselected and CD8-selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivo. Clin Immunol Immunopathol 1994; 72:237-47.
-
(1994)
Clin Immunol Immunopathol
, vol.72
, pp. 237
-
-
Steger, G.G.1
Pierce, W.C.2
Figlin, R.3
-
18
-
-
0028047913
-
Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells.
-
Tanguay S, Killion JJ. Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. Lymphokine and Cytokine Research 1994; 4:259-63.
-
(1994)
Lymphokine Cytokine Research
, vol.4
, pp. 259
-
-
Tanguay, S.1
Killion, J.J.2
-
19
-
-
0021020342
-
A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.
-
Czerkinsky CC, Nielsson LA, Nygren H, Ouchterlony O, Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983; 65:109-21.
-
(1983)
J Immunol Methods
, vol.65
, pp. 109
-
-
Czerkinsky, C.C.1
Nielsson, L.A.2
Nygren, H.3
Ouchterlony, O.4
Tarkowski, A.5
-
20
-
-
0023945701
-
Reverse ELISPOT assay for clonal analysis of cytokine production. Enumeration of gamma-interferon secreting cells.
-
Czerkinsky CC, Andersson G, Ekre HP, et al. Reverse ELISPOT assay for clonal analysis of cytokine production. Enumeration of gamma-interferon secreting cells. J Immunol Methods 1988; 110:29-36.
-
(1988)
J Immunol Methods
, vol.110
, pp. 29
-
-
Czerkinsky, C.C.1
Andersson, G.2
Ekre, H.P.3
-
21
-
-
0027488482
-
Number of interleulin-4-and interferon-gamma-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation.
-
elGhazali GE, Paulie S, Andersson G, et al. Number of interleulin-4-and interferon-gamma-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation. Eur J Immunol 1993; 23:2740-5.
-
(1993)
Eur J Immunol
, vol.23
, pp. 2740
-
-
elGhazali, G.E.1
Paulie, S.2
Andersson, G.3
-
22
-
-
0027461902
-
Detection of single cells secreting IFN-gamma, IL-6, and IL-10 in irreversible rejected human kidney allografts, and their modulation by IL-2 and IL-4.
-
Merville P, Pouteil-Noble C, Wijdenes J, Potaux L, Touraine JL, Banchereau J. Detection of single cells secreting IFN-gamma, IL-6, and IL-10 in irreversible rejected human kidney allografts, and their modulation by IL-2 and IL-4. Transplantation 1993; 55:639-46.
-
(1993)
Transplantation
, vol.55
, pp. 639
-
-
Merville, P.1
Pouteil-Noble, C.2
Wijdenes, J.3
Potaux, L.4
Touraine, J.L.5
Banchereau, J.6
-
23
-
-
0026719744
-
Reverse ELISPOT assay for clonal analysis of cytokine production. II. Enumeration of interleukin-1-secreting cells amplified (avidin-biotin anti-peroxidase) assay.
-
Nordstrom I, Ferrua B. Reverse ELISPOT assay for clonal analysis of cytokine production. II. Enumeration of interleukin-1-secreting cells amplified (avidin-biotin anti-peroxidase) assay. J Immunol Methods 1992; 150:199-206.
-
(1992)
J Immunol Methods
, vol.150
, pp. 199
-
-
Nordstrom, I.1
Ferrua, B.2
-
24
-
-
0029953952
-
Detection and quantification of blood-derived CD8-T lymphocytes secreting TNFa in response to HLA-A2.1-binding melanoma and viral peptide antigens.
-
Herr W, Schneider J, Lohse AW, et al. Detection and quantification of blood-derived CD8-T lymphocytes secreting TNFa in response to HLA-A2.1-binding melanoma and viral peptide antigens. J Immunol Methods 1996; 191:131-43.
-
(1996)
J Immunol Methods
, vol.191
, pp. 131
-
-
Herr, W.1
Schneider, J.2
Lohse, A.W.3
-
25
-
-
0030794379
-
Characterization of T cell response to herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) using a TNF-beta ELISPOT cytokine assay.
-
Schmid DS, Thieme ML, Gary Jr, HE Reeves WC. Characterization of T cell response to herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) using a TNF-beta ELISPOT cytokine assay. Arch Virol 1997; 142:1659-71.
-
(1997)
Arch Virol
, vol.142
, pp. 1659
-
-
Schmid, D.S.1
Thieme, M.L.2
Gary, H.E.3
Reeves, W.C.4
-
26
-
-
0031825621
-
Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment.
-
Medhat A, Shehata M, Bucci K, et al. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis 1998; 178:512-19.
-
(1998)
J Infect Dis
, vol.178
, pp. 512
-
-
Medhat, A.1
Shehata, M.2
Bucci, K.3
-
28
-
-
0031590669
-
Evaluation of the interferon-γ ELISPOT-assay for quantification of peptide-specific T lymphocytes from peripheral blood.
-
Schmittel A, Keilholz U, Scheibenbogen C. Evaluation of the interferon-γ ELISPOT-assay for quantification of peptide-specific T lymphocytes from peripheral blood. J Immunol Methods 1997; 210:167-74.
-
(1997)
J Immunol Methods
, vol.210
, pp. 167
-
-
Schmittel, A.1
Keilholz, U.2
Scheibenbogen, C.3
-
29
-
-
0031009421
-
Computer-assisted, quantitative cytokine enzyme-linked immunospot analysis of human immune effector cell function.
-
Cui Y, Chang LJ. Computer-assisted, quantitative cytokine enzyme-linked immunospot analysis of human immune effector cell function. Biotechniques 1997; 22:1146-9.
-
(1997)
Biotechniques
, vol.22
, pp. 1146
-
-
Cui, Y.1
Chang, L.J.2
-
30
-
-
0030934741
-
The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor a spots in response to peptide antigens.
-
+ T lymphocytes producing tumor necrosis factor a spots in response to peptide antigens. J Immunol Methods 1997; 203:141-52.
-
(1997)
J Immunol Methods
, vol.203
, pp. 141
-
-
Herr, W.1
Linn, B.2
Leister, N.3
-
31
-
-
0028875568
-
Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies.
-
Yi Q, österborg A, Bergenbrant S, Mellstedt H, Holm G, Lefvert AK. Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies. Blood 1995; 86:3043-9.
-
(1995)
Blood
, vol.86
, pp. 3043
-
-
Yi, Q.1
österborg, A.2
Bergenbrant, S.3
Mellstedt, H.4
Holm, G.5
Lefvert, A.K.6
-
32
-
-
0030916776
-
Analysis of the T cell response to tumor and viral peptide antigens by an IFN-γ-ELISPOT assay.
-
Scheibenbogen C, Lee K-H, Stevanovic S, et al. Analysis of the T cell response to tumor and viral peptide antigens by an IFN-γ-ELISPOT assay. Int J Cancer 1997; 71:932-6.
-
(1997)
Int J Cancer
, vol.71
, pp. 932
-
-
Scheibenbogen, C.1
Lee, K.-H.2
Stevanovic, S.3
-
33
-
-
85026176090
-
-
Scheibenbogen C, Schmittel A, Keilholz U, et al. Phase II trial of vaccination with tyrosinase peptides and GM-CSF in melanoma. J Immunother. in press, 2000.
-
Scheibenbogen C, Schmittel A, Keilholz U, et al. Phase II trial of vaccination with tyrosinase peptides and GM-CSF in melanoma. J Immunother. in press, 2000.
-
-
-
-
34
-
-
85026172539
-
-
Lewis JJ, Janetzki S, Wang S, et al. Phase I trial of vaccination with tyrosinase peptide plus QS-21 in melanoma (Abstract 1650). J Clin Oncol 1998;17.
-
Lewis JJ, Janetzki S, Wang S, et al. Phase I trial of vaccination with tyrosinase peptide plus QS-21 in melanoma (Abstract 1650). J Clin Oncol 1998;17.
-
-
-
-
36
-
-
0031027541
-
A sensitive ELISPOT assay for detection of CD8-T-lymphocytes specific for HLA class I binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
-
Scheibenbogen C, Lee K-H, Mayer S, et al. A sensitive ELISPOT assay for detection of CD8-T-lymphocytes specific for HLA class I binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients. Clin Cancer Res 1997; 3:221-6.
-
(1997)
Clin Cancer Res
, vol.3
, pp. 221
-
-
Scheibenbogen, C.1
Lee, K.-H.2
Mayer, S.3
-
37
-
-
0033524348
-
Induction of tyrosinase-reactive T cells by the treatment with dacarbacin, cisplatin, interferon-alpha—interleukin-2 in patients with metastatic melanoma.
-
Schmittel A, Keilholz U, Max R, Thiel E, Scheibenbogen C. Induction of tyrosinase-reactive T cells by the treatment with dacarbacin, cisplatin, interferon-alpha—interleukin-2 in patients with metastatic melanoma. Int J Cancer 1999; 80:39-43.
-
(1999)
Int J Cancer
, vol.80
, pp. 39
-
-
Schmittel, A.1
Keilholz, U.2
Max, R.3
Thiel, E.4
Scheibenbogen, C.5
-
38
-
-
0032054736
-
Human melanoma-specific, noncytolytic CD8+ T cells that can synthesize type I cytokine.
-
+ T cells that can synthesize type I cytokine. Cancer Res 1998; 58:1363-6.
-
(1998)
Cancer Res
, vol.58
, pp. 1363
-
-
Chakraborty, N.G.1
Mukherji, B.2
-
39
-
-
0029984048
-
Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide.
-
Brossart P, Bevan MJ. Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide. J Exp Med 1996; 183:2449-58.
-
(1996)
J Exp Med
, vol.183
, pp. 2449
-
-
Brossart, P.1
Bevan, M.J.2
-
40
-
-
0030765987
-
Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine.
-
+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine. Int J Cancer 1997; 72:972-6.
-
(1997)
Int J Cancer
, vol.72
, pp. 972
-
-
Reynolds, S.R.1
Oratz, R.2
Shapiro, R.L.3
-
41
-
-
0342378189
-
A comparison between ELISPOT methods for the detection of cytokine producing cells: greater sensitivity and specificity using ELISA plates as compared to nitrocellulose membranes.
-
Rönnelid J, Klareskog L. A comparison between ELISPOT methods for the detection of cytokine producing cells: greater sensitivity and specificity using ELISA plates as compared to nitrocellulose membranes. J Immunol Methods 1997; 200:17-26.
-
(1997)
J Immunol Methods
, vol.200
, pp. 17
-
-
Rönnelid, J.1
Klareskog, L.2
-
42
-
-
85026166544
-
-
Weber JS, Spears L, Jeffery G, et al. A phase I trial of a MART-1 HLA-A2 restricted peptide vaccine for resected high risk melanoma (Abstract 1676). J Clin Oncol 1998;17.
-
Weber JS, Spears L, Jeffery G, et al. A phase I trial of a MART-1 HLA-A2 restricted peptide vaccine for resected high risk melanoma (Abstract 1676). J Clin Oncol 1998;17.
-
-
-
-
43
-
-
0031716189
-
Immunization of patients with melanoma peptides vaccines: immunologic assessment using the ELISPOT assay.
-
Pass HA, Schwarz SL, Wunderlich JR, Rosenberg SA. Immunization of patients with melanoma peptides vaccines: immunologic assessment using the ELISPOT assay. Cancer J Sci Am 1998; 4:316-23.
-
(1998)
Cancer J Sci Am
, vol.4
, pp. 316
-
-
Pass, H.A.1
Schwarz, S.L.2
Wunderlich, J.R.3
Rosenberg, S.A.4
-
44
-
-
85026171255
-
-
Mammi C, Herr W, Del Bello D, et al. Analysis by ELISPOT assay of CTL precursors specific for HLA-A2.1-binding ErbB-2 peptides in breast cancer patients (Abstract 62). Proc Am Assoc Cancer Res 1998;39.
-
Mammi C, Herr W, Del Bello D, et al. Analysis by ELISPOT assay of CTL precursors specific for HLA-A2.1-binding ErbB-2 peptides in breast cancer patients (Abstract 62). Proc Am Assoc Cancer Res 1998;39.
-
-
-
-
45
-
-
85026167403
-
-
Salgaller ML, Lodge PA, Tjoa BA, et al. Monitoring of prostate-specific membrane antigen (PSMA)-specific immune responses and prostate markers in a phase II clinical trial with patients infused with dendritic cells pulsed with PSMA-derived peptides (Abstract 1187). Proc Am Assoc Cancer Res 1998;39.
-
Salgaller ML, Lodge PA, Tjoa BA, et al. Monitoring of prostate-specific membrane antigen (PSMA)-specific immune responses and prostate markers in a phase II clinical trial with patients infused with dendritic cells pulsed with PSMA-derived peptides (Abstract 1187). Proc Am Assoc Cancer Res 1998;39.
-
-
-
-
46
-
-
85026159547
-
-
Valone FH, Small EJ, Whisenant S, et al. Immunotherapy of hormone refractory prostate cancer with antigen-pulsed dendritic cells: a phase I/II trial (Abstract 1334). J Clin Oncol 1998;17.
-
Valone FH, Small EJ, Whisenant S, et al. Immunotherapy of hormone refractory prostate cancer with antigen-pulsed dendritic cells: a phase I/II trial (Abstract 1334). J Clin Oncol 1998;17.
-
-
-
-
47
-
-
0029983701
-
Modulation of anti-idiotypic immune response by immunization with autologous M-component protein in multiple myeloma patients.
-
Bergenbrant S, Yi Q, österborg A, et al. Modulation of anti-idiotypic immune response by immunization with autologous M-component protein in multiple myeloma patients. Br J Haematol 1996; 92:840-6.
-
(1996)
Br J Haematol
, vol.92
, pp. 840
-
-
Bergenbrant, S.1
Yi, Q.2
österborg, A.3
-
48
-
-
0032055911
-
Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8+ and CD4-specific T-cell responses.
-
+ and CD4-specific T-cell responses. Blood 1998; 91:2459-66.
-
(1998)
Blood
, vol.91
, pp. 2459
-
-
österborg, A.1
Yi, Q.2
Henriksson, L.3
-
49
-
-
15144345621
-
Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
-
Hanke T, Blanchard TJ, Schneider J, et al. Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. J Gen Virol 1998; 70:83-90.
-
(1998)
J Gen Virol
, vol.70
, pp. 83
-
-
Hanke, T.1
Blanchard, T.J.2
Schneider, J.3
-
50
-
-
0030932988
-
Induction of mucosal immunity against herpes simplex viris by plasmid DNA immunization.
-
Kukulin N, Daheshia M, Karem K, Manickan E, Rouse BT. Induction of mucosal immunity against herpes simplex viris by plasmid DNA immunization. J Virol 1997; 74:3138-45.
-
(1997)
J Virol
, vol.74
, pp. 3138
-
-
Kukulin, N.1
Daheshia, M.2
Karem, K.3
Manickan, E.4
Rouse, B.T.5
|